3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
9
Breast Neoplasms
6
Neoplasms
4
Colorectal Neoplasms
3
Multiple Myeloma
2
Insulin Resistance
2
Cardiotoxicity
2
Weight Loss
1
Warts
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Fatigue
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Cachexia
1
Brenner Tumor
1
Bone Metastases
1
Body Weight
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Exercise
×
Clear all
No trials found.